International Isocyanate Institute Inc is located in Mountain Lakes, NJ. The organization was established in 1973. According to its NTEE Classification (M40) the organization is classified as: Safety Education, under the broad grouping of Public Safety, Disaster Preparedness & Relief and related organizations. As of 12/2023, International Isocyanate Institute Inc employed 3 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. International Isocyanate Institute Inc is a 501(c)(6) and as such, is described as a "Business League, Chambers of Commerce, or Real Estate Board" by the IRS.
For the year ending 12/2023, International Isocyanate Institute Inc generated $3.0m in total revenue. This represents relatively stable growth, over the past 9 years the organization has increased revenue by an average of 0.9% each year. All expenses for the organization totaled $3.7m during the year ending 12/2023. While expenses have increased by 3.3% per year over the past 9 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE INSTITUTE PROMOTES AND FURTHERS THE INTEREST OF THE PUBLIC, THE USERS, AND THE MANUFACTURERS OF CERTAIN CHEMICALS IN THE SAFE HANDLING OF THE SUBSTANCES
Describe the Organization's Program Activity:
Part 3 - Line 4a
SCIENTIFIC PROGRAM- INCLUDES FUNDING RESEARCH PROJECTS, REVIEW OF SCIENTIFIC RESEARCH REPORTS AND DISTRIBUTION OF INFORMATION
SCIENTIFIC PROGRAM- INCLUDES FUNDING RESEARCH PROJECTS,
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Tibor Klement Ad Hoc Membe | Trustee | $0 | |
Tom Feige Am VP | Officer | $0 | |
Christine Mendoza-Frohn President | Officer | $0 | |
Hitoshi Muramatsu VP Ap | Officer | $0 | |
Patrick Plehiers Managing Dir | Officer | $0 | |
Erik Vangronsveld Eu Vice Pres | Officer | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Charles River Laboratories Animal Studies | 12/30/23 | $904,734 |
Iccr In Vitro Studie | 12/30/23 | $206,241 |
University Of Groningen Cell Line Studi | 12/30/23 | $199,428 |
Fraunhofer Ime Sig Plant Study | 12/30/23 | $254,495 |
Basf Se Animal Studies | 12/30/23 | $659,922 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $2,900,205 |
Investment income | $133,021 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $3,035,790 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $684,714 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $0 |
Payroll taxes | $0 |
Fees for services: Management | $0 |
Fees for services: Legal | $19,030 |
Fees for services: Accounting | $19,435 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $0 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $0 |
Travel | $96,072 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $85,107 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $0 |
Insurance | $0 |
All other expenses | $110,027 |
Total functional expenses | $3,726,992 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $293,295 |
Savings and temporary cash investments | $3,269,792 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $71,576 |
Net Land, buildings, and equipment | $0 |
Investments—publicly traded securities | $0 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $3,634,663 |
Accounts payable and accrued expenses | $665,867 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $665,867 |
Net assets without donor restrictions | $2,968,796 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,634,663 |